Trump Plans Pay for Vaccine ‘Injury’ Care

The Trump administration is finalizing a rule that would reimburse doctors who diagnose, treat and counsel patients for vaccine side effects, in a change The Guardian reported as part of a broader remaking of US vaccine policy under health secretary Robert F. Kennedy Jr.

On paper, paying clinicians for care sounds tidy enough. People who are harmed by a medical intervention should not be ignored, and serious vaccine side effects do exist, even if they are rare. The problem, experts quoted by The Guardian argue, is the incentive structure around what counts as “injury,” who gets to define it, and what this policy appears designed to build: not only a payment stream, but a larger official-looking archive of claims that can be used to cast doubt on vaccination itself.

Kennedy has paired the reimbursement plan with the creation of a vaccine “injury” research center at the National Institutes of Health and with efforts to reshape the Vaccine Injury Compensation Program, or VICP. That program was created in 1986 to compensate people for genuine vaccine-related harm through a process that is typically faster and less burdensome than ordinary litigation.

Dorit Reiss, a law professor at UC Law San Francisco, told The Guardian that paying doctors to report side effects to the federal Vaccine Adverse Event Reporting System risks creating “the wrong incentives,” particularly if some providers come to see this work as a revenue source. VAERS is an early-warning database, not a proof machine; reports can be important without establishing that a vaccine caused a given medical problem. That distinction matters because a swelling pile of reports can be politically useful even when causation remains unproven.

Peter Hotez, dean of Baylor College of Medicine’s National School of Tropical Medicine, told the paper that Kennedy has been steadily eroding public confidence in vaccines while favoring products sold through the wellness industry. That is a harsh reading, but it is not an eccentric one. Kennedy’s public career has long been built on vaccine distrust, and The Guardian ties the current policy shift to that longer campaign.

The conflict question is harder to wave away. Before his confirmation hearing in January 2025, Kennedy disclosed $2.5 million in income from referrals for vaccine-related lawsuits, according to The Guardian. The paper also notes his involvement in litigation against Merck over its HPV vaccine, in lawsuits that were settled for more than $50 million in June 2026. After the hearing, Kennedy said his son would receive the money expected from that settlement share; The Guardian said it remains unclear whether that happened.

Emily Hilliard, an HHS spokesperson, told The Guardian the department “categorically” rejects claims that Kennedy is pursuing personal gain or trying to dismantle American medicine.

There is a real human stake underneath the ideology and the legal maneuvering. Reiss told The Guardian that if false or weak claims proliferate, they can drown out people with legitimate injuries who need compensation and care. That is the sort of bureaucratic cruelty that arrives disguised as concern: a system built in the name of the injured becoming harder for the genuinely injured to use.

The oldest trick in health politics is to take a small truth and make it carry a lie. Vaccines can, in rare cases, cause serious harm. It does not follow that public confidence should be organized around suspicion, or that federal policy should reward the production of more suspicion-shaped evidence.